Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ignace Lasters

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
Idrugs : the Investigational Drugs Journal|April 1, 2009
Strategies for preclinical immunogenicity assessment of protein therapeuticsPhilippe Stas, Ignace Lasters
Medecine Sciences : M/S|December 29, 2009
[Immunogenicity of therapeutic antibodies]Philippe Stas, Ignace Lasters
Proteins|May 16, 2002
Fast and accurate side-chain topology and energy refinement (FASTER) as a new method for protein structure optimizationJohan Desmet, Jan Spriet, Ignace Lasters
Bioinformatics (Oxford, England)|August 31, 2004
SABmark--a benchmark for sequence alignment that covers the entire known fold spaceIvo Van Walle, Ignace Lasters, Lode Wyns
Proteins|February 22, 2003
Consistency matrices: quantified structure alignments for sets of related proteinsIvo Van Walle, Ignace Lasters, Lode Wyns
Bioinformatics (Oxford, England)|February 14, 2004
Align-m--a new algorithm for multiple alignment of highly divergent sequencesIvo Van Walle, Ignace Lasters, Lode Wyns
Expert Opinion on Biological Therapy|February 21, 2007
Immunogenicity screening in protein drug developmentIvo Van Walle, Yannick Gansemans, Paul W H I Parren, et al.
Proteins|November 5, 2004
Anchor profiles of HLA-specific peptides: analysis by a novel affinity scoring method and experimental validationJohan Desmet, Geert Meersseman, Nathalie Boutonnet, et al.
Journal of Virology|July 5, 2002
Comparison of predicted scaffold-compatible sequence variation in the triple-hairpin structure of human imunodeficiency virus type 1 gp41 with patient dataNathalie Boutonnet, Wouter Janssens, Carlo Boutton, et al.
Frontiers in Bioscience : a Journal and Virtual Library|May 30, 2008
TNF: a moonlighting protein at the interface between cancer and infectionHarald Hundsberger, Alexander Verin, Christoph Wiesner, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Idrugs : the Investigational Drugs Journal|April 1, 2009
Strategies for preclinical immunogenicity assessment of protein therapeuticsPhilippe Stas, Ignace Lasters
Medecine Sciences : M/S|December 29, 2009
[Immunogenicity of therapeutic antibodies]Philippe Stas, Ignace Lasters
Proteins|May 16, 2002
Fast and accurate side-chain topology and energy refinement (FASTER) as a new method for protein structure optimizationJohan Desmet, Jan Spriet, Ignace Lasters
Bioinformatics (Oxford, England)|August 31, 2004
SABmark--a benchmark for sequence alignment that covers the entire known fold spaceIvo Van Walle, Ignace Lasters, Lode Wyns
Proteins|February 22, 2003
Consistency matrices: quantified structure alignments for sets of related proteinsIvo Van Walle, Ignace Lasters, Lode Wyns
Bioinformatics (Oxford, England)|February 14, 2004
Align-m--a new algorithm for multiple alignment of highly divergent sequencesIvo Van Walle, Ignace Lasters, Lode Wyns
Expert Opinion on Biological Therapy|February 21, 2007
Immunogenicity screening in protein drug developmentIvo Van Walle, Yannick Gansemans, Paul W H I Parren, et al.
Proteins|November 5, 2004
Anchor profiles of HLA-specific peptides: analysis by a novel affinity scoring method and experimental validationJohan Desmet, Geert Meersseman, Nathalie Boutonnet, et al.
Journal of Virology|July 5, 2002
Comparison of predicted scaffold-compatible sequence variation in the triple-hairpin structure of human imunodeficiency virus type 1 gp41 with patient dataNathalie Boutonnet, Wouter Janssens, Carlo Boutton, et al.
Frontiers in Bioscience : a Journal and Virtual Library|May 30, 2008
TNF: a moonlighting protein at the interface between cancer and infectionHarald Hundsberger, Alexander Verin, Christoph Wiesner, et al.
Pageof 2